Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment
about
E3 ubiquitin ligase synoviolin is involved in liver fibrogenesisRheumatoid Arthritis, Immunosenescence and the Hallmarks of AgingRole of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1βCells of the synovium in rheumatoid arthritis. Macrophages.Treatment of fibromyalgia and its symptoms.Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis.Differential Effects of IL-17A and TNF-α on Osteoblastic Differentiation of Isolated Synoviocytes and on Bone Explants from Arthritis Patients.PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints.RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis.Ubiquitin ligase substrate identification through quantitative proteomics at both the protein and peptide levels.Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes
P2860
Q28748731-A645954A-CC19-4900-A51D-9262421839DBQ33555281-F6DA80E5-839A-4825-94DF-CA1EF8962E1BQ33728533-F4141B7C-7F91-43BC-83B1-1D9ED0FA571DQ35527134-FC3785CD-C534-4BBD-913F-54EA41A07778Q36465497-44D26B9B-D4F8-40E7-BACF-8292F9CC293BQ36904884-F3B9D25C-143F-46C1-A984-1C97F55984A5Q38131960-000208C6-C43C-41D5-BEAA-7A98AD1674D4Q39327736-8562624A-97F0-4AA2-A7E8-2DEEB1F787D5Q40106950-4BA7AC7E-A0E4-4086-AFE2-0F24CF4F5AEFQ40214786-BE6579D5-57D2-46E1-8C79-1D40C3795222Q42176050-D78B784A-63A5-4C1B-9A07-F180430EEA3FQ54369171-8563015A-B41C-4C89-9087-E5E70730007EQ58756411-19864BE9-93BE-4B5E-AEC0-49BF58BCD78A
P2860
Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Overexpression of synoviolin i ...... onders to infliximab treatment
@ast
Overexpression of synoviolin i ...... onders to infliximab treatment
@en
Overexpression of synoviolin i ...... onders to infliximab treatment
@nl
type
label
Overexpression of synoviolin i ...... onders to infliximab treatment
@ast
Overexpression of synoviolin i ...... onders to infliximab treatment
@en
Overexpression of synoviolin i ...... onders to infliximab treatment
@nl
prefLabel
Overexpression of synoviolin i ...... onders to infliximab treatment
@ast
Overexpression of synoviolin i ...... onders to infliximab treatment
@en
Overexpression of synoviolin i ...... onders to infliximab treatment
@nl
P2093
P356
P1476
Overexpression of synoviolin i ...... onders to infliximab treatment
@en
P2093
Assia Eljaafari
Bruno Mougin
Hubert Marotte
Jean-Luc Blond
Myew-Ling Toh
Umar Jhumka
P304
P356
10.1002/ART.21926
P407
P577
2006-07-01T00:00:00Z